Policy & Regulations
Bank Indonesia has been under pressure to support President Prabowo’s growth agenda.
1
S&P flags policy uncertainty after Bank Indonesia governor quits, affirms ratings
2
Agritech startup Rize triples valuation, and other updates
3
SG-based Psalion launches $50m fund, aims at next wave of blockchain adoption
4
India healthcare M&A hits record value as pharma takes centre stage
5
Sovereign capital deepens its bet on SE Asia’s data centre boom
More Stories
SWFs are becoming much more than just allocators
How Carousell hit EBITDA breakeven by ‘building backwards’
GenZero leads Singapore-based PCG Global’s pre-Series A round
Editor’s Take: The Week That Was—July 20-25
Private rockets, big cheques: India’s space sector enters new era
Deals
Rize has completed a $20m equity allotment that more than tripled its post-money valuation.
Venture Capital
The vehicle is Psalion’s third and largest venture fund to date.
Analysis
Sun Pharma’s acquisition of Organon contributed nearly 89% of the sector’s M&A deal value.
Recent deals have seen GIC, ADIA and CPP Investments back platforms with growing footprints across SE Asia.
Singapore
The group reported revenue of $151.2m for the year ended Dec 31, 2025.
Greater China
Shein’s valuation fell from $98.2b following a round in 2022 to $64b after another funding round in 2024.
The announcement comes as HSBC moves to launch a new AI centre in Singapore in the second half of 2026.
India
Ultratech plans to raise an aggregate of $517.80 million through bonds.
Rest of Asia
Brookfield, which has more than $1 trillion in AUM, is committing $500 million to the fund.
